OverviewSuggest Edit

Schrodinger is a provider of molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The company offers a technology platform, which integrates physics-based molecular simulations and machine learning for a broader exploration of chemical space.

HQNew York, NY, US
Employee Ratings4.9
Overall CultureC+

Latest Updates

Employees (est.) (Dec 2019)392
Job Openings72
Revenue (FY, 2020)$108.1 M(+27%)
Share Price (Dec 2021)$34.8(+2%)
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Schrodinger

Ramy Farid

Ramy Farid

President, Chief Executive Officer and Director
Robert Abel

Robert Abel

Executive Vice President, Chief Computational Scientist
Shane Brauner

Shane Brauner

Senior Vice President and Chief Information Officer
Karen Akinsanya

Karen Akinsanya

Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D
Jennifer Daniel

Jennifer Daniel

Senior Vice President and Chief HR Officer
Mike Beachy

Mike Beachy

Senior Vice President, Software Development
Show more

Schrodinger Office Locations

Schrodinger has offices in New York, Cambridge, Portland, San Diego and in 5 other locations
New York, NY, US (HQ)
120 W 45th St # 9
Cambridge, MA, US
222 Third St #2230
Portland, OR, US
One Main Place, 101 SW Main St #1300
San Diego, CA, US
10201 Wateridge Cir #220
Shanghai, CN
220, 2nd Floor, Building, 333 Qinjiang Rd, Xuhui Qu
Mannheim, DE
Glücksteinallee 25
Show all (11)

Schrodinger Financials and Metrics

Schrodinger Revenue

Embed Graph
View revenue for all periods
Schrodinger's revenue was reported to be $108.1 m in FY, 2020

Revenue (Q1, 2021)


Gross profit (Q1, 2021)


Gross profit margin (Q1, 2021), %


Net income (Q1, 2021)


EBIT (Q1, 2021)


Market capitalization (31-Dec-2021)


Closing stock price (31-Dec-2021)


Cash (31-Mar-2021)



Schrodinger's current market capitalization is $2.1 b.
USDFY, 2017FY, 2018FY, 2019FY, 2020



Revenue growth, %


Cost of goods sold


Gross profit

USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021



Cost of goods sold


Gross profit


Gross profit Margin, %

USDFY, 2017FY, 2018FY, 2019FY, 2020



Accounts Receivable


Prepaid Expenses


Current Assets

USDQ3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021



Accounts Receivable


Prepaid Expenses


Current Assets

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income


Depreciation and Amortization


Accounts Payable


Cash From Operating Activities

USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income


Depreciation and Amortization


Accounts Payable


Cash From Operating Activities

USDFY, 2017

Financial Leverage

-1.3 x
Show all financial metrics

Schrodinger Operating Metrics

Schrodinger's Active Customers was reported to be 1.3 k in FY, 2019.
FY, 2017FY, 2018FY, 2019

Active Customers

1.04 k1.15 k1.27 k

Customers with >$1M in Annual Contract Value


Customers with >$100K in Annual Contract Value


Patents and Patent Applications

Show all operating metrics

Schrodinger Acquisitions / Subsidiaries

Company NameDateDeal Size
Faxian Therapeutics, LLC
Reo Discovery Limited
Schrödinger GmbH
Schrödinger, KK
Schrödinger LLC
Synaptic Science LLC

Schrodinger Revenue Breakdown

Embed Graph

Schrodinger revenue breakdown by business segment: 22.0% from Drug Discovery and 78.0% from Software

Schrodinger revenue breakdown by geographic segment: 7.1% from Rest of World, 16.8% from Japan, 20.5% from Europe and 55.7% from United States

Schrodinger Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset


out of 100

CSRHub logo

Schrodinger Online and Social Media Presence

Embed Graph

Schrodinger Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



Learn more on Comparably

Schrodinger News and Updates

Schrodinger Announces $2.7 Billion Collaboration With Bristol Myers Squibb

The multi-year collaboration will combine Schrödinger’s leading physics-based computational software platform and drug discovery capabilities with Bristol Myers Squibb's expertise in development and commercialization to advance small molecule therapeutics for targets in oncology, immunology, and ne…

Schrodinger Blogs

Using Modeling to Develop Healthier and More Sustainable Food

Schrödinger scientist Jeffrey Sanders recently sat down (virtually) with Evan Flach at the 4th Food Innovation and Engineering (FOODIE) Conference that took place in December. Their conversation touched on how using modeling and simulation tools can help to more accurately predict food formulation o…

At the Forefront of Structure-Based Drug Discovery

On January 14, 2021, Schrödinger acquired XTAL BioStructures, Inc., a private company based in the Greater Boston area that provides structural biology services, including biophysical methods, protein production and purification, and X-ray crystallography, to the pharmaceutical and biotechnology ind…

A Digital Platform for Molecular Design: Inside the Schrödinger-Bayer Collaboration

Arguably one of the most important challenges facing the pharma industry today is the efficient adoption of digital platforms to improve the discovery and development of new medicines. At Bayer, we have tackled this challenge with widespread digitalization efforts across our R&D organization, ba…

Executing on Diversity, Equity and Inclusion in the Workplace

As we close 2021, diversity, equity and inclusion (DEI) is a phrase we have all heard in passing, but the question is: do we know what it really means and how to instill these values in the workplace? For some, it may mean the ability to work effectively with one another regardless of backgrounds or…

Schrödinger Inaugural Employee Art Exhibition

“Sciences provide an understanding of a universal experience, Arts are a universal understanding of a personal experience. They are both avatars of human creativity.”  – Mae Jemison On December 7th, 2021, Schrödinger hosted its Inaugural Employee Art Exhibition at its new Headquarters in New York Ci…

From the Bench to the Computer: Incorporating Molecular Modeling Into Materials R&D

When it comes to molecular modeling, experimental scientists typically face two major barriers: misperception and trust. The most common misperception is that molecular modeling requires significant coding expertise or a Ph.D. in computational chemistry or theoretical physics. With regard to trust, …
Show more

Schrodinger Frequently Asked Questions

  • When was Schrodinger founded?

    Schrodinger was founded in 1990.

  • Who are Schrodinger key executives?

    Schrodinger's key executives are Ramy Farid, Robert Abel and Shane Brauner.

  • How many employees does Schrodinger have?

    Schrodinger has 392 employees.

  • What is Schrodinger revenue?

    Latest Schrodinger annual revenue is $108.1 m.

  • What is Schrodinger revenue per employee?

    Latest Schrodinger revenue per employee is $275.8 k.

  • Who are Schrodinger competitors?

    Competitors of Schrodinger include Simulations Plus, Dotmatics and Certara.

  • Where is Schrodinger headquarters?

    Schrodinger headquarters is located at 120 W 45th St # 9, New York.

  • Where are Schrodinger offices?

    Schrodinger has offices in New York, Cambridge, Portland, San Diego and in 5 other locations.

  • How many offices does Schrodinger have?

    Schrodinger has 11 offices.